Hub Genes Involved in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma

被引:1
|
作者
Liu, Baiyi [1 ]
Wang, Xiaoxiao [1 ]
Wu, Nan [1 ]
Liu, Feng [1 ]
Rao, Huiying [1 ]
机构
[1] Peking Univ Peoples Hosp, Peking Univ Hepatol Inst, Beijing Key Lab Hepatitis C & Immunotherapy Liver, Beijing Int Cooperat Base Sci & Technol NAFLD Diag, Beijing, Peoples R China
关键词
Nonalcoholic fatty liver disease (NAFLD); hepatocellular carcinoma (HCC); biomarkers; progression; prognosis; FIBROSIS STAGE; INFLAMMATION; VERSICAN; CELLS; NASH; STEATOHEPATITIS; PREVALENCE; PLATELETS; APOPTOSIS; PROTEIN;
D O I
10.2174/0109298673288887240212065116
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. With an increasing number of patients, NAFLD has been identified as a risk factor for Hepatocellular Carcinoma (HCC). The precise pathophysiology of NAFLD-related HCC has not been completely understood recently.Objective We analyzed the hub genes related to NAFLD and HCC to predict the risk of NAFLD progressing to HCC.Methods Two datasets of NAFLD were used to identify differentially expressed genes. Lasso-Cox regression analysis was performed to determine a gene model to predict the risk of the progression from NAFLD to HCC. Three validation datasets were analyzed to evaluate the performance of the gene model, including normal and NAFLD with fibrosis, NAFLD with fibrosis and NAFLD-related HCC, and normal and NASH-related HCC.Results Seven genes, including COL1A1, TIPM1, VCAN, FOS, CD79A, CXCL9, and VWF, were identified as the hub genes, and then a gene model was constructed. By calculating, the area under the receiver operating characteristic curves (AUCs) for risk prediction were 0.97, 0.886, and 0.751 in the three validation datasets, respectively. Gene set enrichment analysis indicated that the MAPK, TGF beta, p53, PPAR, insulin signaling pathways, and fatty acid metabolism were significantly upregulated in the high-risk group. GTPase activity and intrinsic apoptotic signaling pathway had significant upregulation in the low-risk group.Conclusion The seven hub genes may predict the risk of NAFLD developing into HCC by mediating the potential molecular mechanism, which could be used as biomarkers for predicting the progression, diagnosis, and treatment of NAFLD.
引用
收藏
页数:21
相关论文
共 50 条
  • [31] Hepatocellular carcinoma on the background of nonalcoholic fatty liver disease: epidemiological update
    Desjonqueres, Elvire
    Gigante, Elia
    HEPATOMA RESEARCH, 2022, 8
  • [32] Nonalcoholic fatty liver disease related hepatocellular carcinoma in a developing country
    Jamwal, Kapil Dev
    Chhibber, Guresh Kumar
    Sarin, Shiv Kumar
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 362 - 362
  • [33] Clinicopathological features of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease
    Mikuriya, Yoshihiro
    Tashiro, Hirotaka
    Kobayashi, Tsuyoshi
    Kuroda, Shintaro
    Abe, Tomoyuki
    Hashimoto, Masakazu
    Ohdan, Hideki
    LANGENBECKS ARCHIVES OF SURGERY, 2015, 400 (04) : 471 - 476
  • [34] From Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: A Systems Understanding
    Rozman, Damjana
    DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (02) : 238 - 241
  • [35] Role of MicroRNAs in the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
    Zhang, Cheng
    Wang, Ping
    Li, Yongqiang
    Huang, Changxin
    Ni, Wei
    Chen, Yidan
    Shi, Junping
    Chen, Gongying
    Hu, Xiangrong
    Ye, Meng
    Duan, Shiwei
    Wang, Kaifeng
    ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY, 2019, 302 (02): : 193 - 200
  • [36] Statins, diabetes, obesity, nonalcoholic fatty liver disease, and hepatocellular carcinoma
    Han, Jun
    Yan, Wen-Tao
    Quan, Bing
    Wang, Ming-Da
    Yang, Tian
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2019, 18 (02) : 202 - 202
  • [37] Hepatocellular Carcinoma Screening and Nonalcoholic Fatty Liver Disease: How is it Different?
    Acharya, Subrat K.
    Bopanna, Sawan
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2020, 10 (05) : 518 - 524
  • [38] Locoregional Therapies for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
    Susman, Stephen
    Santoso, Breanna
    Makary, Mina S.
    BIOMEDICINES, 2024, 12 (10)
  • [39] From Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: A Systems Understanding
    Damjana Rozman
    Digestive Diseases and Sciences, 2014, 59 : 238 - 241
  • [40] Clinicopathological features of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease
    Yoshihiro Mikuriya
    Hirotaka Tashiro
    Tsuyoshi Kobayashi
    Shintaro Kuroda
    Tomoyuki Abe
    Masakazu Hashimoto
    Hideki Ohdan
    Langenbeck's Archives of Surgery, 2015, 400 : 471 - 476